While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Some users experience side-effects such as nausea, diarrhoea and fatigue. Other clinical studies have found that some ...
Gold nanoparticles help lose fat more effectively than a common weight-loss drug, improving body fat levels and organ health in obese rats.
High-dose gold nanoparticle treatment outperformed orlistat in reversing obesity-related damage in rats, according to ...
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
1d
News Medical on MSNBlockbuster drug for diabetes and obesity could also help reduce alcohol intakeThe blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.
Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results